Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DEFERIPRONE
- Thalidomide and Hydroxyurea Combination in β-Thalassemia Patients
- NAC Effect on Iron Overload and Blood Transfusion in β-thalassemia Major
- Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
- Iron Chelation in the Prevention of Secondary Degeneration After Stroke
- Clinical Curative Effect Evaluation Study of Treatment of Oral Deferiprone Tablets in Aceruloplasminaemia Patients
- Open Trail of γIFN for Friedreich Ataxia
- Safety and Acceptability of Deferiprone Delayed Release Tablets in Patients With Systemic Iron Overload
- Deferiprone for Ruptured Brain Aneurysm
- Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Children
- Conservative Iron Chelation as a Disease-modifying Strategy in Amyotrophic Lateral Sclerosis
- Deferiprone to Delay Dementia (The 3D Study)
- The Potential Hepatoprotective Effect of Metformin in Patients With Beta Thalassemia Major
- Characterisation of Relative Bioavailability With Bioequivalence Assessment of Deferiprone Tablets After Oral Single Dose Administration
- Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
- Oxidative Stress and Apoptosis of Energy Metabolism by Deferiprone From the Circulating Lymphocytes
- A Pilot of the Feasibility of Using the Iron-Chelator Deferiprone on Mild Cognitive Impairment
- Study of Parkinson's Early Stage With Deferiprone
- Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease
- Compassionate Use of Deferiprone in Patients With PKAN
- Effect of Deferiprone on Oxidative-Stress and Iron-Overload in Low Risk Transfusion-Dependent MDS Patients
- Comparison of Deferiprone Extended Release Tablets and Ferriprox Immediate Release Tablets in Healthy Volunteers
- Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects
- Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias
- Comparison of Deferiprone Delayed Release Tablets and Deferiprone Oral Solution in Healthy Volunteers
- Clinical Trial of Deferasirox Combination Treatment With Deferiprone In Thalassaemia Patients
- Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects
- Pilot Study of the Pharmacokinetic Profile of Deferiprone Sustained-Release Formulation in Healthy Volunteers
- Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration
- An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients
- Focal Accumulation of Iron in Cerebral Regions in Early ALS (Amyotrophic Lateral Sclerosis) Patients
- Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
- Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
- A Blinded, Placebo-Controlled Study of the Safety and Pharmacokinetics of Single Doses of Intravenous Deferiprone in Healthy Volunteers
- Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects
- Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease
- Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients
- Evaluation of the Efficacy in Decreasing Iron Absorption in Patients With Congenital Dyserythropoietic Anemia Type I by Treatment With LOSEC
- An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal Impairment
- An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers
- Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)
- Pharmacokinetic Study of Deferiprone in Paediatric Patients
- Combination Deferasirox and Deferiprone for Severe Iron Overload in Thalassemia
- Effect of Antioxidant Cocktail in Beta-thalassemia/Hb E Patients
- A Pilot Clinical Trial With the Iron Chelator Deferiprone in Parkinson's Disease
- Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload
- Efficacy and Safety of Deferiprone in Patients With Chronic Kidney Disease Undergoing a Cardiac Catheterization and Receiving Contrast Agent
- Deferiprone for the Prevention of Contrast-Induced Acute Kidney Injury
- Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's Disease
- Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)
- A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia
- Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major
- Efficacy Study of the Use of Sequential DFP-DFO Versus DFP
- A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia
- Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patients
- Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients
- Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients
- Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
- Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)
- Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
- Efficacy Study in Removing Excess Iron From the Heart
- Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major
- Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)
- Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone
Clinical trials list
click for details